Confronta i metodi

	Strumento di screening per i sintomi premestruali	Questionario sulla Qualità della Vita Specifica per la Menopausa
Campo	Ostetricia e ginecologia	Ostetricia e ginecologia
Famiglia	Process / pipeline	Process / pipeline
Anno di origine	2003	1996
Ideatore	Steiner, M., Macdougall, M., & Brown, E.	Hilditch, J. R., Lewis, J., Peter, A., van Maris, B., Ross, A., Franssen, E., Guyatt, G. H.
Tipo	Self-report	Self-report
Fonte seminale	Steiner, M., Macdougall, M., & Brown, E. (2003). The Premenstrual Symptoms Screening Tool (PSST) for clinicians. Archives of Women's Mental Health, 6(3), 203-209.	Hilditch, J. R., Lewis, J., Peter, A., van Maris, B., Ross, A., Franssen, E., Guyatt, G. H., Lethargy, S., & Improvement, T. (1996). A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas, 24(3), 161-175.
Alias	PSST, Premenstrual Symptom Screening	MENQOL, Menopause Quality of Life
Correlati	3	3
Sintesi	The Premenstrual Symptoms Screening Tool (PSST) is a brief, 19-item self-report questionnaire designed to screen for premenstrual dysphoric disorder (PMDD) and assess the severity of premenstrual symptoms. Developed by Steiner, Macdougall, and Brown in 2003, the PSST efficiently identifies women with clinically significant cyclical mood and physical symptoms warranting diagnostic evaluation and potential pharmacological or psychological treatment.	The Menopause-Specific Quality of Life Questionnaire (MENQOL) is a 29-item self-report instrument designed to assess quality of life in women experiencing menopausal symptoms. Developed by Hilditch and colleagues in 1996, the MENQOL captures four interrelated symptom domains: vasomotor symptoms (hot flushes, night sweats), psychosocial symptoms (mood, stress, anxiety), physical symptoms (fatigue, aches, sleep), and sexual symptoms. It is the primary menopause-specific outcome measure used in hormone replacement therapy trials and menopause research.